Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


05.11.2018

1 Blood
2 Haematologica
2 N Engl J Med
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Blood

  1. DREYLING M, Klapper W, Rule S
    Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!
    Blood. 2018 Nov 1. pii: blood-2017-08-737502. doi: 10.1182/blood-2017-08-737502.
    PubMed     Text format     Abstract available


    Haematologica

  2. HAGENBEEK A, Mooij H, Zijlstra J, Lugtenburg P, et al
    Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study.
    Haematologica. 2018 Oct 31. pii: haematol.2018.196899.
    PubMed     Text format    

  3. BURKHARD R, Keller I, Arambasic M, Juskevicius D, et al
    TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-kappaB mediated signaling in B-cells.
    Haematologica. 2018 Oct 31. pii: haematol.2018.201590.
    PubMed     Text format     Abstract available


    N Engl J Med

  4. ADVANI R, Flinn I, Popplewell L, Forero A, et al
    CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
    N Engl J Med. 2018;379:1711-1721.
    PubMed     Text format     Abstract available

  5. BACH PB
    National Coverage Analysis of CAR-T Therapies - Policy, Evidence, and Payment.
    N Engl J Med. 2018;379:1396-1398.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  6. HUANG Q, Chen L, Yang L, Xie X, et al
    MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.
    Proc Natl Acad Sci U S A. 2018;115:E3368-E3377.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: